Literature DB >> 29528413

'Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.' Do we have enough pieces to solve the pyrazinamide puzzle?

R M Anthony1, A L den Hertog2, D van Soolingen1.   

Abstract

A low pH was assumed to be required for the activity of pyrazinoic acid (the active form of pyrazinamide) against Mycobacterium tuberculosis, but recently activity has been demonstrated at neutral pH. Renewed interest in pyrazinamide has led to an increasing number of potential targets and the suspicion that pyrazinamide is a 'dirty drug'. However, it is our opinion that the recent demonstration that pyrazinoic acid is active against PanD provides an alternative explanation for the secret of pyrazinamide's unusual activity. In this article we propose that PanD is the primary target of pyrazinoic acid but expression of pyrazinoic acid susceptibility requires an intact stress response. As the mycobacterial stress response requires the interaction of a number of genes, disruption of any could result in an inability to enter the susceptible phenotype. We believe this model can explain most of the recent observations of the seemingly diverse spectrum of activity of pyrazinamide.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29528413     DOI: 10.1093/jac/dky060

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.

Authors:  Pooja Gopal; Gerhard Grüber; Véronique Dartois; Thomas Dick
Journal:  Trends Pharmacol Sci       Date:  2019-11-06       Impact factor: 14.819

Review 2.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

3.  Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.

Authors:  Timothy J de Wet; Digby F Warner; Valerie Mizrahi
Journal:  Acc Chem Res       Date:  2019-07-30       Impact factor: 22.384

Review 4.  The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors.

Authors:  Kyle H Rohde; Leonardo Sorci
Journal:  Front Microbiol       Date:  2021-01-26       Impact factor: 5.640

Review 5.  Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents.

Authors:  Hailey S Butman; Timothy J Kotzé; Cynthia S Dowd; Erick Strauss
Journal:  Front Cell Infect Microbiol       Date:  2020-12-15       Impact factor: 5.293

6.  The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery.

Authors:  Tianao Yuan; Joshua M Werman; Nicole S Sampson
Journal:  RSC Chem Biol       Date:  2021-01-13

7.  Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay.

Authors:  Roberto Alcántara; Patricia Fuentes; Lisette Marin; Daniela E Kirwan; Robert H Gilman; Mirko Zimic; Patricia Sheen
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

8.  Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase.

Authors:  Olivier Sheik Amamuddy; Thommas Mutemi Musyoka; Rita Afriyie Boateng; Sophakama Zabo; Özlem Tastan Bishop
Journal:  Comput Struct Biotechnol J       Date:  2020-05-18       Impact factor: 7.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.